Bio-Techne Corp (Bio-Techne) manufactures, develops and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s product portfolio includes ELISA kits, ELISpot kits, enzymes, Luminex assays, proteins, GMP products and instruments. Bio-Techne's custom service offerings comprise antibody services, targeted protein degradation services, licensing, cell and gene therapy services, compound library services, ELISA services and gene engineering services among others. It conducts research in the areas of cancer, cardiovascular, cell and gene therapy, covid-19, glycobiology, immunology, immuno-oncology, metabolism, neuroscience, pharmacology and stem cells. It serves biotechnology research and clinical diagnostic markets. The company operates in the UK, North America and China. Bio-Techne is headquartered in Minneapolis, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bio-Techne Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Bio-Techne Corp Company Overview
- Bio-Techne Corp Company Snapshot
- Bio-Techne Corp Pipeline Products and Ongoing Clinical Trials Overview
- Bio-Techne Corp - Pipeline Analysis Overview
- Business Description
- Bio-Techne Corp - Key Facts
- Bio-Techne Corp - Major Products and Services
- Bio-Techne Corp Pipeline Products by Development Stage
- Bio-Techne Corp Pipeline Products Overview
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy Product Overview
- Biofluid Nucleic Acid Kit - Alzheimer's Disease
- Biofluid Nucleic Acid Kit - Alzheimer's Disease Product Overview
- Biofluid Nucleic Acid Kit - Cardiovascular Disease
- Biofluid Nucleic Acid Kit - Cardiovascular Disease Product Overview
- Biofluid Nucleic Acid Kit - Chronic Kidney Disease
- Biofluid Nucleic Acid Kit - Chronic Kidney Disease Product Overview
- Biofluid Nucleic Acid Kit - Parkinson's Disease
- Biofluid Nucleic Acid Kit - Parkinson's Disease Product Overview
- Biofluid-Based Molecular Diagnostic Test - Brain Cancer
- Biofluid-Based Molecular Diagnostic Test - Brain Cancer Product Overview
- BIONIC Liquid Biopsy - Bladder Cancer
- BIONIC Liquid Biopsy - Bladder Cancer Product Overview
- Companion Diagnostic Test - Huntington's Disease
- Companion Diagnostic Test - Huntington's Disease Product Overview
- CTCscope System
- CTCscope System Product Overview
- Diagnostic Assay - Breast Cancer Signature
- Diagnostic Assay - Breast Cancer Signature Product Overview
- Diagnostic Assay - IDH1
- Diagnostic Assay - IDH1 Product Overview
- Diagnostic Test - Parkinson's Disease
- Diagnostic Test - Parkinson's Disease Product Overview
- Ella - Ophthalmology Disorders
- Ella - Ophthalmology Disorders Product Overview
- ELLA Cytokine Storm Panel - COVID-19
- ELLA Cytokine Storm Panel - COVID-19 Product Overview
- ExoTRU Kidney Transplant Rejection Test
- ExoTRU Kidney Transplant Rejection Test Product Overview
- Immunomagnetic Micro-Aperture Chip System
- Immunomagnetic Micro-Aperture Chip System Product Overview
- Midi Lung Cancer Panel
- Midi Lung Cancer Panel Product Overview
- miRNA Based Sequencing Test - Colon Cancer
- miRNA Based Sequencing Test - Colon Cancer Product Overview
- miRNA Based Sequencing Test - Esophageal Cancer
- miRNA Based Sequencing Test - Esophageal Cancer Product Overview
- miRNA Based Sequencing Test - Lung Cancer
- miRNA Based Sequencing Test - Lung Cancer Product Overview
- miRNA Based Sequencing Test - Pancreatic Cancer
- miRNA Based Sequencing Test - Pancreatic Cancer Product Overview
- Next-Generation Solid Tumor Mutation Panel
- Next-Generation Solid Tumor Mutation Panel Product Overview
- RNAscope - Lymphoma
- RNAscope - Lymphoma Product Overview
- RNAscope - Zika Virus
- RNAscope - Zika Virus Product Overview
- RNAscope HPV Assay - Cervical Cancer
- RNAscope HPV Assay - Cervical Cancer Product Overview
- Signature CF Expand
- Signature CF Expand Product Overview
- Sjogren Syndrome Assay
- Sjogren Syndrome Assay Product Overview
- Wet- And Dry-Bench Kit
- Wet- And Dry-Bench Kit Product Overview
- Bio-Techne Corp - Key Competitors
- Bio-Techne Corp - Key Employees
- Bio-Techne Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Bio-Techne Corp, Recent Developments
- May 10, 2023: Bio-Techne announces launch of Kappa and Lambda RNAscope ISH probes as analyte specific reagents (ASRs) for the detection of immunoglobulin kappa and lambda light chains mRNA
- May 03, 2023: Bio-techne releases third quarter fiscal 2023 results
- Apr 13, 2023: Bio-Techne to showcase innovative cancer research, cell therapy and manufacturing tools at AACR 2023 conference
- Apr 12, 2023: Bio-techne to Host Conference Call on May 3, 2023, to Announce Third Quarter 2023 Financial Results
- Apr 05, 2023: bio-techne celebrates milestone with more than 1,000 Ella instruments now in operation
- Feb 14, 2023: Bio-Techne and Cell Signaling Technology announce partnership to validate simple western antibodies
- Feb 02, 2023: Bio-Techne Releases Second Quarter Fiscal 2023 Results
- Jan 26, 2023: Bio-Techne launches the MauriceFlex system, adding cIEF fractionation capability to the gold standard maurice assays
- Jan 17, 2023: Bio-Techne to Host Conference Call on February 2, 2023 to Announce Second Quarter 2023 Financial Results
- Dec 05, 2022: Bio-techne releases mitobrilliant fluorescent dyes, providing a next-generation tool for imaging mitochondria in live and fixed cells
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Bio-Techne Corp Pipeline Products and Ongoing Clinical Trials Overview
- Bio-Techne Corp Pipeline Products by Equipment Type
- Bio-Techne Corp Pipeline Products by Indication
- Bio-Techne Corp, Key Facts
- Bio-Techne Corp, Major Products and Services
- Bio-Techne Corp Number of Pipeline Products by Development Stage
- Bio-Techne Corp Pipeline Products Summary by Development Stage
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy - Product Status
- AmplideX SMA Plus Kit - Spinal Muscular Atrophy - Product Description
- Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status
- Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description
- Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status
- Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description
- Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status
- Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description
- Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status
- Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description
- Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status
- Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description
- BIONIC Liquid Biopsy - Bladder Cancer - Product Status
- BIONIC Liquid Biopsy - Bladder Cancer - Product Description
- Companion Diagnostic Test - Huntington's Disease - Product Status
- Companion Diagnostic Test - Huntington's Disease - Product Description
- CTCscope System - Product Status
- CTCscope System - Product Description
- Diagnostic Assay - Breast Cancer Signature - Product Status
- Diagnostic Assay - Breast Cancer Signature - Product Description
- Diagnostic Assay - IDH1 - Product Status
- Diagnostic Assay - IDH1 - Product Description
- Diagnostic Test - Parkinson's Disease - Product Status
- Diagnostic Test - Parkinson's Disease - Product Description
- Ella - Ophthalmology Disorders - Product Status
- Ella - Ophthalmology Disorders - Product Description
- ELLA Cytokine Storm Panel - COVID-19 - Product Status
- ELLA Cytokine Storm Panel - COVID-19 - Product Description
- ExoTRU Kidney Transplant Rejection Test - Product Status
- ExoTRU Kidney Transplant Rejection Test - Product Description
- Immunomagnetic Micro-Aperture Chip System - Product Status
- Immunomagnetic Micro-Aperture Chip System - Product Description
- Midi Lung Cancer Panel - Product Status
- Midi Lung Cancer Panel - Product Description
- miRNA Based Sequencing Test - Colon Cancer - Product Status
- miRNA Based Sequencing Test - Colon Cancer - Product Description
- miRNA Based Sequencing Test - Esophageal Cancer - Product Status
- miRNA Based Sequencing Test - Esophageal Cancer - Product Description
- miRNA Based Sequencing Test - Lung Cancer - Product Status
- miRNA Based Sequencing Test - Lung Cancer - Product Description
- miRNA Based Sequencing Test - Pancreatic Cancer - Product Status
- miRNA Based Sequencing Test - Pancreatic Cancer - Product Description
- Next-Generation Solid Tumor Mutation Panel - Product Status
- Next-Generation Solid Tumor Mutation Panel - Product Description
- RNAscope - Lymphoma - Product Status
- RNAscope - Lymphoma - Product Description
- RNAscope - Zika Virus - Product Status
- RNAscope - Zika Virus - Product Description
- RNAscope HPV Assay - Cervical Cancer - Product Status
- RNAscope HPV Assay - Cervical Cancer - Product Description
- Signature CF Expand - Product Status
- Signature CF Expand - Product Description
- Sjogren Syndrome Assay - Product Status
- Sj
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diagnostics
- Abcam Plc
- Agilent Technologies Inc
- BD Biosciences
- Beckman Coulter Inc
- Cytiva
- GE HealthCare Technologies Inc
- HyTest Ltd
- LGC Clinical Diagnostics Inc
- Luminex Corp
- Meso Scale Discovery
- PeproTech Inc
- PerkinElmer Inc
- Quanterix Corp
- Streck Inc
- Thermo Fisher Scientific Inc
- Waters Corp
